Normal View Dyslexic View

Long-term oncological outcomes of robotic mastectomy for breast cancer: a randomized clinical trial

BJSA
BJS Academy
0000-0000
BJS Foundation Limited
London, UK
Toesca A, Magnoni F, Sangalli C, Maisonneuve P, Gottardi A, De Scalzi AM et al.
BJS 2026; 113: znag007.
Some 80 women were included, with comparable oncological outcomes between robotic and open nipple sparing mastectomy at a median follow-up of 6.5 years. Five-year overall survival was 97.1 per cent in both groups, five-year disease-free survival was similar between robotic and open group (88.2 versus 88.6 per cent), as was breast cancer-specific survival (91.0 versus 91.2 per cent).
Comment: Robotic nipple-sparing mastectomy matches open surgery for 5-year oncological outcomes, although this small trial wasn't powered to prove it.

Related articles


16 August 2024

21-Gene assay to inform chemotherapy benefit in node-positive breast cancer.

Kalinsky K, Barlow WE, Gralow JR, Meric-Bernstam F, Albain KS, Hayes DF et al.
N Engl J Med 2021; 385: 2336-2347

1 January 2022

Event-free survival with pembrolizumab in early triple-negative breast cancer.

Schmid P, Cortes J, Dent R, Pusztai L, McArthur H, Kummel S et al, for the KEYNOTE-522 Investigators.
N Engl J Med 2022; 386: 556-567.

1 March 2022
Copied!